The impact of acute urinary morbidity on late urinary function after permanent prostate brachytherapy
Authors:
- Gregory S. MerrickGMGregory S. Merrick
- 1 October 2007
- journal article
- Published by Elsevier in Brachytherapy
- Vol. 6 (4) , 258-266
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Selecting patients with pretreatment postvoid residual urine volume less than 100 mL may favorably influence brachytherapy-related urinary morbidityUrology, 2005
- Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidityInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- INTERMEDIATE TERM BIOCHEMICAL-FREE PROGRESSION AND LOCAL CONTROL FOLLOWING 125 IODINE BRACHYTHERAPY FOR PROSTATE CANCERJournal of Urology, 2005
- Extracapsular Radiation Dose Distribution After Permanent Prostate BrachytherapyAmerican Journal of Clinical Oncology, 2003
- 1???125 Versus Pd-103 for Low-Risk Prostate CancerThe Cancer Journal, 2002
- Temporal resolution of urinary morbidity following prostate brachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Comparison of the 5-Year Outcome and Morbidity of Three-Dimensional Conformal Radiotherapy Versus Transperineal Permanent Iodine-125 Implantation for Early-Stage Prostatic CancerJournal of Clinical Oncology, 1999
- Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43Medical Physics, 1995